Small Molecules

21 Jun 2007 Pipeline update – CNS 7056
21 Jun 2007 Alexza Pharmaceuticals Expands Staccato(R) Migraine Product Portfolio
21 Jun 2007 Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
21 Jun 2007 Pfizer Receives Approvable Letter From FDA For Maraviroc
21 Jun 2007 Theravance Announces Enrollment of Last Patient in Phase 3 Hospital-Acquired Pneumonia Clinical Program with Investigational Antibiotic, Telavancin
21 Jun 2007 Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
20 Jun 2007 OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
20 Jun 2007 Bayer and Onyx submit new european marketing authorization application to EMEA for Nexavar to treat liver cancer
20 Jun 2007 FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone
20 Jun 2007 Nuvo provides update on discussions with the FDA related to Pennsaid approval
20 Jun 2007 Sativex® receives Qualifying Notice for approval in Canada for the relief of Cancer Pain
20 Jun 2007 DeveloGen and Teva Enter into Exclusive License Agreement for DeveloGen’s Protein Kinase B Technology for the Treatment of Cancer
20 Jun 2007 Surface Logix Commences Phase 2A Clinical Trial of SLx-2101 in Hypertension
20 Jun 2007 Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
20 Jun 2007 Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
19 Jun 2007 Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
19 Jun 2007 Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
19 Jun 2007 Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
19 Jun 2007 Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
19 Jun 2007 NicOx provides an update on NCX 4016
19 Jun 2007 BioCryst presents Phase I Peramivir data at the options for the control of influenza conference
19 Jun 2007 Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
19 Jun 2007 Novelos Therapeutics announces encouraging results in ongoing phase 2 ovarian cancer trial at Dana-Farber/Partners Cancer Care
19 Jun 2007 EPIX Receives FDA Response to Vasovist(TM) Appeal
16 Jun 2007 Collegium Pharmaceutical Inc., Announces the Filing of IND for Abuse Deterrent Sustained Release Opioid Product

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up